GLUE R&D to Revenue
Monte Rosa Therapeutics Inc · R&D to Revenue
GLUE R&D to Revenue
Latest reported114.42%period ending
GLUE FY R&D/Revenue (0.00% → 114.42%)
Latest values, visible window
High-resolution chart · PNG
GLUE r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 114.4156% | |
| 160.7508% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |